Transpek Industry Ltd

Transpek Industry Ltd

₹ 1,532 2.01%
09 May - close price
About

Incorporated in 1965, Transpek Industry Ltd manufactures and exports a range of chemicals[1]

Key Points

Business Overview:[1][2]
TIL, a part of the Excel Group, is a global supplier of chlorinated products serving diverse sectors including pharmaceuticals, agrochemicals, dyes, and pigments. The company has core expertise in handling chlorine and sulphur, with in-house developed processes for key chemicals like Thionyl Chloride and various acid and alkyl chlorides. It also specializes in complex chemical reactions such as chlorination, acid chlorination, alcohol chlorination, Friedel-Crafts reactions, sulfonation, and amidation, enabling it to offer tailored solutions for advanced chemical applications.

  • Market Cap 855 Cr.
  • Current Price 1,532
  • High / Low 1,896 / 1,100
  • Stock P/E 17.6
  • Book Value 1,334
  • Dividend Yield 0.91 %
  • ROCE 9.15 %
  • ROE 6.87 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 1.15 times its book value
  • Company has been maintaining a healthy dividend payout of 20.6%

Cons

  • The company has delivered a poor sales growth of 2.81% over past five years.
  • Company has a low return on equity of 9.20% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
143 211 216 196 203 162 121 148 148 152 163 170 165
126 182 181 154 163 140 108 121 129 136 140 146 133
Operating Profit 16 30 35 42 40 23 13 28 19 16 23 24 32
OPM % 11% 14% 16% 21% 20% 14% 11% 19% 13% 11% 14% 14% 19%
4 4 4 4 5 12 4 5 5 11 5 5 8
Interest 3 4 5 5 6 4 3 4 3 3 3 3 3
Depreciation 8 8 8 8 8 9 9 9 11 12 13 12 13
Profit before tax 10 22 27 33 31 21 6 20 9 12 12 14 25
Tax % -16% 26% 25% 25% 28% 25% 46% 29% 35% 20% 20% 22% 21%
11 16 20 25 22 16 3 14 6 9 10 11 19
EPS in Rs 20.25 29.36 35.79 44.26 40.05 28.38 5.35 25.21 10.10 16.63 17.10 19.07 34.46
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
269 290 284 317 361 595 566 339 599 827 580 650
242 251 236 263 314 478 447 292 499 676 497 555
Operating Profit 27 38 48 53 47 117 118 47 100 151 82 95
OPM % 10% 13% 17% 17% 13% 20% 21% 14% 17% 18% 14% 15%
8 11 2 7 10 18 17 17 24 14 25 29
Interest 14 13 11 9 12 19 16 10 11 19 14 12
Depreciation 9 9 8 9 10 14 26 29 30 33 38 50
Profit before tax 12 27 32 42 35 101 94 26 84 113 56 62
Tax % 38% 18% 33% 29% 25% 35% 22% 9% 22% 26% 31% 21%
8 22 21 30 26 66 73 23 65 83 39 49
EPS in Rs 12.82 37.41 36.24 53.67 47.26 117.70 130.59 41.73 117.09 149.46 69.03 87.26
Dividend Payout % 19% 13% 21% 17% 19% 17% 10% 18% 19% 18% 20% 23%
Compounded Sales Growth
10 Years: 8%
5 Years: 3%
3 Years: 3%
TTM: 12%
Compounded Profit Growth
10 Years: 11%
5 Years: -8%
3 Years: -11%
TTM: 27%
Stock Price CAGR
10 Years: 19%
5 Years: -2%
3 Years: -2%
1 Year: -9%
Return on Equity
10 Years: 13%
5 Years: 10%
3 Years: 9%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 50 69 85 200 241 306 333 374 479 581 668 740
101 77 64 88 203 144 116 111 137 145 123 62
87 77 55 93 116 143 134 109 143 155 169 193
Total Liabilities 244 229 209 386 566 599 589 599 764 887 966 1,001
106 92 94 117 179 236 287 287 295 365 397 360
CWIP 5 5 10 13 56 33 19 14 16 24 6 5
Investments 4 5 5 131 144 149 118 142 196 238 321 328
129 126 100 125 188 180 166 156 258 260 242 307
Total Assets 244 229 209 386 566 599 589 599 764 887 966 1,001

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
26 19 44 47 7 128 111 35 47 111 98 135
-9 14 -16 -31 -103 -45 -33 -17 -70 -13 -32 -30
-17 -33 -27 -17 96 -83 -77 -3 9 -94 -64 -56
Net Cash Flow -0 -0 1 -1 0 -0 0 15 -14 4 3 48

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 100 103 59 78 94 57 58 82 60 52 58 58
Inventory Days 89 68 111 91 87 68 70 82 77 54 82 74
Days Payable 146 114 60 83 103 72 73 81 65 45 58 70
Cash Conversion Cycle 43 57 110 85 78 54 54 83 72 61 81 61
Working Capital Days 21 64 61 62 88 42 60 91 75 60 76 67
ROCE % 17% 22% 28% 23% 13% 27% 24% 7% 18% 20% 9% 9%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
57.48% 57.49% 57.49% 57.47% 57.47% 57.47% 57.47% 57.47% 57.47% 57.47% 57.47% 57.47%
1.85% 1.85% 1.85% 1.80% 1.85% 1.86% 0.95% 0.05% 0.05% 0.05% 0.03% 0.03%
2.09% 2.00% 1.99% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79% 1.86% 1.86% 1.86%
0.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
37.84% 38.68% 38.68% 38.95% 38.89% 38.88% 39.78% 40.69% 40.69% 40.62% 40.64% 40.63%
No. of Shareholders 13,79413,77213,57113,45312,93513,30813,41114,66914,38914,20213,89213,599

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls